Dihydrocodeine (Tartrate)
Generic medicine reference
Not yet clinically reviewed
This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.
Overview
Dihydrocodeine is a mild narcotic analgesic and antitussive, also called as drocode. Chemically Dihydrocodeine (Tartrate) is identified as 4,5a-epoxy-3-methoxy-17-methylmorphinan-6a-ol. Dihydrocodeine (Tartrate) is effective to relieve moderate to severe pain and swelling.
Indications
Dihydrocodeine (Tartrate) is primarily indicated in conditions like Cough, Diarrhea, Moderate to severe pain.
Contraindications
Dihydrocodeine (Tartrate) is contraindicated in conditions like Respiratory failure, Bronchospasm, Productive cough, Hepatic failure, Reye's syndrome, Hemophilia, Known or suspected GI obstruction
Side Effects
The severe or irreversible adverse effects of Dihydrocodeine (Tartrate), which give rise to further complications include Dependence. Dihydrocodeine (Tartrate) produces potentially life-threatening effects which include Bronchospasm, which are responsible for the discontinuation of Dihydrocodeine (Tartrate) therapy. The signs and symptoms that are produced after the acute over dosage of Dihydrocodeine (Tartrate) include Hypotension, Unconsciousness, Miosis, Depression, Myoclonic twitching, Hypoventilation. The symptomatic adverse reactions produced by Dihydrocodeine (Tartrate) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Nausea, Vomiting, Constipation, Sedation, Hallucination, Euphoria, Headache, Confusion, Fatigue.
Warnings
Dihydrocodeine should be used with caution in patients with diseases of the kidney, liver or heart, asthma or other breathing problems, stomach ulcers, bleeding disorders, high blood pressure, severe diarrhea, drug dependency and of any drug allergy. It should be used with caution while driving or engaging in activities requiring alertness. Limit alcohol consumption because it may add to the dizziness or drowsiness effects of this drug, heavy drinking of alcohol may make stomach and intestines more susceptible to the irritating effects of this medication increasing the risk of stomach or intestinal bleeding. This medication should be used during pregnancy only when clearly needed. This medication is not recommended during lactation.
High Risk Groups
Drug should not be given to Pediatrics, Pregnant Mothers, Geriatrics, and Neonates. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
0.286 to 0.857 mg/kg (0.57 (0.5715)) 4 hourly PO — As Required
Child Dosage
0.4 to 1.2 mg/kg (0.8 (0.8)) 6 hourly Oral — Recommended for 5-12 Yrs of Children
0.5 to 1 mg/kg (0.75 (0.75)) As recommended. PO — for 4 to 6 hourly . Max 30mg
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Dihydrocodeine (Tartrate) was found.
Storage
Caps Store Below 40°C. Protect from Sunlight and Moisture.
Available Brands in Pakistan
No brands are recorded for this generic.